Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Bio2Skin, the first clinically skin-preserving biomaterial replacing silicones/acrylate as medical skin adhesives

Objective

External medical devices, such as ostomy pouches, wound dressings or wearable electronic devices, require the use of medical adhesives for their attachment to the skin. However, prolonged use of current medical adhesives is associated with serious adverse skin reactions, MARSI (Medical Adhesives-Related Skin Injuries). This underreported issue is prevalent in 25% of wound care cases and is associated with enormous health care and economic burdens. BH4U aims to address this challenge with Bio2Skin. A patented revolutionary glueless medical adhesive that uses the natural features of the skin to establish a water-based link and overcomes the disadvantages of acrylic/silicone adhesives. Bio2Skin is a bio-based, cost-effective, recyclable solution offering gentle, safe adhesion and kind removal. The product, with a potential of >250M EUR by 2030, will be sold under license to medical adhesive manufacturers and external medical devices manufacturers.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC - HORIZON EIC Accelerator

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2024-ACCELERATOR-02

See all projects funded under this call

Coordinator

BESTHEALTH4U LDA
Net EU contribution
€ 2 492 571,00
Address
PRACA CONDE DE AGROLONGO, EDIFICIO GNRATION N 123
4700-312 BRAGA
Portugal
SME
Yes
Region
Continente Norte Cávado
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data